X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Natco Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NATCO PHARMA   ACTAVIS
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
ACTAVIS
Dec-14
NATCO PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs87718,501-   
Low Rs42411,285-   
Sales per share (Unadj.) Rs223.43,331.6-  
Earnings per share (Unadj.) Rs31.1-415.7-  
Cash flow per share (Unadj.) Rs40.3305.7-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs219.57,226.1-  
Shares outstanding (eoy) m33.07265.90-   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.94.5 65.1%   
Avg P/E ratio x20.9-35.8 -58.4%  
P/CF ratio (eoy) x16.148.7 33.1%  
Price / Book Value ratio x3.02.1 143.7%  
Dividend payout %16.10-   
Avg Mkt Cap Rs m21,5043,960,121 0.5%   
No. of employees `000NA21.6 0.0%   
Total wages/salary Rs m1,1280-   
Avg. sales/employee Rs ThNM41,012.3-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-5,117.9-  
INCOME DATA
Net Sales Rs m7,389885,865 0.8%  
Other income Rs m167-2,211 -7.6%   
Total revenues Rs m7,556883,654 0.9%   
Gross profit Rs m1,793113,802 1.6%  
Depreciation Rs m304191,822 0.2%   
Interest Rs m36627,942 1.3%   
Profit before tax Rs m1,290-108,173 -1.2%   
Minority Interest Rs m460-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-7,935 0.0%   
Tax Rs m309-5,561 -5.6%   
Profit after tax Rs m1,027-110,547 -0.9%  
Gross profit margin %24.312.8 188.9%  
Effective tax rate %23.95.1 465.5%   
Net profit margin %13.9-12.5 -111.4%  
BALANCE SHEET DATA
Current assets Rs m3,681466,737 0.8%   
Current liabilities Rs m3,123340,389 0.9%   
Net working cap to sales %7.614.3 53.0%  
Current ratio x1.21.4 86.0%  
Inventory Days Days8958 154.2%  
Debtors Days Days5966 88.5%  
Net fixed assets Rs m7,685108,173 7.1%   
Share capital Rs m3310-   
"Free" reserves Rs m6,6700-   
Net worth Rs m7,2591,921,408 0.4%   
Long term debt Rs m9551,006,856 0.1%   
Total assets Rs m11,9573,521,309 0.3%  
Interest coverage x4.5-2.9 -157.5%   
Debt to equity ratio x0.10.5 25.1%  
Sales to assets ratio x0.60.3 245.6%   
Return on assets %11.7-2.3 -496.8%  
Return on equity %14.2-5.8 -246.0%  
Return on capital %20.7-3.0 -688.3%  
Exports to sales %39.40-   
Imports to sales %5.70-   
Net fx Rs m2,7430-   
CASH FLOW
From Operations Rs m1,440152,120 0.9%  
From Investments Rs m-1,089-364,234 0.3%  
From Financial Activity Rs m-353204,647 -0.2%  
Net Cashflow Rs m-1-7,467 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 67.82 Rs / USD

Compare NATCO PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare NATCO PHARMA With: ALKEM LABORATORIES  TTK HEALTHCARE  STRIDES SHASUN LTD  WOCKHARDT LTD.  CADILA HEALTHCARE  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views On News

NATCO PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 69.6% (Quarterly Result Update)

May 25, 2018 | Updated on May 25, 2018

For the quarter ended March 2018, NATCO PHARMA has posted a net profit of Rs 3 bn (up 69.6% YoY). Sales on the other hand came in at Rs 8 bn (up 32.9% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Jun 22, 2018 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 8-QTR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS